Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email | Twitter) and we will feature it here at the end of each week.
Metabolic, cardio expert joins Pfizer's R&D team
Dr. Morris Birnbaum has joined Pfizer ($PFE) as the company's chief scientific officer for cardiovascular and metabolic disease research. "As the new leader of our Cardiovascular and Metabolic Disease Research Unit, Dr. Birnbaum brings significant scientific expertise that will help us continue the progress of clinical programs in areas of need such as type 2 diabetes, diabetic nephropathy, and hyperlipidemia," Dr. Rod MacKenzie, Group Senior VP, said in a statement. "He is among the leading contributors to our contemporary understanding of the regulation of intracellular metabolism, and an excellent addition to our team. His scientific credentials and knowledge will help Pfizer pursue our goals to achieve industry leadership from the strong position that we currently hold, and to deliver unique therapies for patients." Release
Biotech > Bavarian Nordic has appointed Paul Chaplin as president and CEO. Release > Dr. David Weintraub, a co-founder of LabStyle Innovations ($DRIO), is retiring from the company's board. Release > Insmed ($INSM) has appointed David Brennan to its board of directors. Release > Premune has appointed Eileen Daloia as head of regulatory affairs. Release > Cellectar Biosciences ($CLRB) appointed Chad Kolean as chief financial officer. Release > Charles Rowland has been elected to BIND Therapeutics' ($BIND) board of directors. Release > Islet Sciences ($ISLT) appointed Steven Delmar as chief financial officer. Release > Caris Life Sciences has appointed George Poste as chairman of its scientific advisory board. Release > Synergy Pharmaceuticals ($SGYP) has appointed Paul Eng as senior vice president, drug development. Release > France's Domain Therapeutics has chosen Dr. Youssef Bennani as chairman of the board. Release Diagnostics > Genetic Technologies ($GENE) has appointed Eutillio Buccilli as chief financial officer. Release > Epic Sciences has tapped Jason Adams as vice president of business development. Release CRO > Chiltern International has added Michael Wisniewski as senior executive director of biometrics. Release > Parexel ($PRXL) named Dr. Sy Pretorius its chief scientific officer. Release |
||||
